Table 1.
Characteristics and quality assessment of the included studies.
| Study | Year | Country | Study design | Sample size | Total | MINORS score | |
|---|---|---|---|---|---|---|---|
| ERAS group | Control group | ||||||
| Kennedy et al. | 2007 | United States | Case-control study | 91 | 44 | 135 | 15/24 |
| Vanounou et al. | 2007 | United States | Case-control study | 145 | 64 | 209 | 13/24 |
| Balzano et al. | 2008 | Italy | Case-control study | 252 | 252 | 504 | 15/24 |
| Abu Hilal et al. | 2013 | Britain | Case-control study | 20 | 24 | 44 | 14/24 |
| Kobayashi et al. | 2014 | Japan | Case-control study | 100 | 90 | 190 | 13/24 |
| Braga et al. | 2014 | Italy | Case-control study | 115 | 115 | 230 | 18/24 |
| Coolsen et al. | 2014 | Netherlands | Case-control study | 86 | 97 | 183 | 15/24 |
| Shao et al. | 2015 | China | Case-control study | 325 | 310 | 635 | 14/24 |
| Sutcliffe et al. | 2015 | Britain | Case-control study | 65 | 65 | 130 | 14/24 |
| Williamsson et al. | 2015 | Sweden | Case-control study | 50 | 50 | 100 | 16/24 |
| Morales Soriano et al. | 2015 | Spain | Case-control study | 41 | 44 | 85 | 16/24 |
| Joliat et al. | 2015 | Switzerland | Case-control study | 74 | 87 | 161 | 15/24 |
| Bai et al. | 2016 | China | Case-control study | 124 | 63 | 187 | 15/24 |
| Zouros et al. | 2016 | Greece | Case-control study | 75 | 50 | 125 | 16/24 |
| Deng et al. | 2017 | China | RCT | 76 | 83 | 159 | ∗ |
| Su et al. | 2017 | China | Case-control study | 31 | 31 | 62 | 15/24 |
| Takagi et al. | 2019 | Japan | RCT | 37 | 37 | 74 | ∗ |
| Perinela et al. | 2019 | France | Case-control study | 47 | 30 | 77 | 19/24 |
| Lavu et al. | 2019 | United States | RCT | 37 | 39 | 76 | ∗ |
| Hwang et al. | 2019 | Korea | RCT | 123 | 124 | 247 | ∗ |
RCT: randomized controlled trial; MINORS: methodological index for nonrandomized studies. ∗Unconformity to MINORS score criteria.